These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8491062)

  • 21. Recognizing chronological bias for what it is.
    Berger VW
    Clin Trials; 2011 Dec; 8(6):768; author reply 769. PubMed ID: 22167114
    [No Abstract]   [Full Text] [Related]  

  • 22. Analysis of randomized controlled clinical trials.
    Foley RN
    Methods Mol Biol; 2009; 473():113-26. PubMed ID: 19160734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is it time to abandon complete blinded independent central radiological evaluation of progression in registration trials?
    Pignatti F; Hemmings R; Jonsson B
    Eur J Cancer; 2011 Aug; 47(12):1759-62. PubMed ID: 21641204
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of crossover on the statistical power of randomized studies.
    Weinstein GS; Levin B
    Ann Thorac Surg; 1989 Oct; 48(4):490-5. PubMed ID: 2802849
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How to design a randomised controlled trial.
    Brocklehurst P; Hoare Z
    Br Dent J; 2017 May; 222(9):721-726. PubMed ID: 28496211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Statistics Commentary Series: Commentary No. 30: Propensity Scores.
    Streiner DL
    J Clin Psychopharmacol; 2019; 39(1):9-12. PubMed ID: 30516576
    [No Abstract]   [Full Text] [Related]  

  • 27. Does analysis using "last observation carried forward" introduce bias in dementia research?
    Molnar FJ; Hutton B; Fergusson D
    CMAJ; 2008 Oct; 179(8):751-3. PubMed ID: 18838445
    [No Abstract]   [Full Text] [Related]  

  • 28. Practical approaches for design and analysis of clinical trials of infertility treatments: crossover designs and the Mantel-Haenszel method are recommended.
    Takada M; Sozu T; Sato T
    Pharm Stat; 2015; 14(3):198-204. PubMed ID: 25776032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mega-trials: methodological issues and clinical implications.
    Charlton BG
    J R Coll Physicians Lond; 1995; 29(2):96-100. PubMed ID: 7595900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of stable angina pectoris. "Mother Courage and her children"].
    Nagy V; Czuriga I
    Orv Hetil; 2008 Feb; 149(7):291. PubMed ID: 18258558
    [No Abstract]   [Full Text] [Related]  

  • 31. Interim analyses in 2 x 2 crossover trials.
    Cook RJ
    Biometrics; 1995 Sep; 51(3):932-45. PubMed ID: 7548709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized controlled trials 2: Analysis.
    Foley RN
    Methods Mol Biol; 2015; 1281():177-90. PubMed ID: 25694310
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Confounding in health research.
    Greenland S; Morgenstern H
    Annu Rev Public Health; 2001; 22():189-212. PubMed ID: 11274518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Crossover trials, degrees of freedom, the carryover problem and its dual.
    Senn SJ; Hildebrand H
    Stat Med; 1991 Sep; 10(9):1361-74. PubMed ID: 1925167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interpreting the results of secondary end points and subgroup analyses in clinical trials: should we lock the crazy aunt in the attic?
    Freemantle N
    BMJ; 2001 Apr; 322(7292):989-91. PubMed ID: 11312237
    [No Abstract]   [Full Text] [Related]  

  • 36. Response to comments on 'the use of propensity scores and observational data to estimate randomized controlled trial generalizability bias'.
    Kaizar EE; Vydra TP
    Stat Med; 2014 Feb; 33(3):538-9. PubMed ID: 24395075
    [No Abstract]   [Full Text] [Related]  

  • 37. Confounding, effect modification, and the odds ratio: common misinterpretations.
    Shrier I; Pang M
    J Clin Epidemiol; 2015 Apr; 68(4):470-4. PubMed ID: 25662008
    [No Abstract]   [Full Text] [Related]  

  • 38. INTERMED: a tool for controlling for confounding variables and designing multimodal treatment.
    Huyse FJ; de Jonge P; Lyons JS; Stiefel FC; Slaets JP
    J Psychosom Res; 1999 Apr; 46(4):401-2. PubMed ID: 10340241
    [No Abstract]   [Full Text] [Related]  

  • 39. Letter by Al-Ruzzeh and Navia regarding article, "Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the setting of bleeding after cardiac surgery".
    Al-Ruzzeh S; Navia JL
    Circulation; 2010 Mar; 121(9):e234. PubMed ID: 20212289
    [No Abstract]   [Full Text] [Related]  

  • 40. Issues of study design and data analysis.
    D'Agostino RB
    Inflamm Bowel Dis; 1998 May; 4(2):109-111; discussion 111-3. PubMed ID: 9687216
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.